Concepedia

Curtis Cooper

CC

Statistics

Publications

217

Citations

12.5K

H-Index

56

Active since

1986

Affiliations

University of Ottawa(Current)

Ottawa Hospital

University of Toronto

University of British Columbia

Ottawa Hospital Research Institute

Curtis Cooper is an author at University of Ottawa specializing in infectious diseases, antiviral therapy, and viral hepatitis.

ORCID

Publications per year

1986–2025

217

Publications

217

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 850 citations · Full text

, , +17

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Péter Ferenci, David Bernstein, Jacob Lalezari et al. · New England Journal of Medicine · 2014 · 695 citations · Full text

, , +16

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

Marc Bourlière, Stuart C. Gordon, Steven L. Flamm et al. · New England Journal of Medicine · 2017 · 565 citations

, , +15

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 467 citations · Full text

, , +17

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

Edward J. Mills, Celestin Bakanda, Josephine Birungi et al. · Annals of Internal Medicine · 2011 · 418 citations

, , +17

1–5 of 217